RSS Feeds
Search

Companies

Companies

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis
Mar 2011 - 4 pages - $500
Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010
Dec 2010 - 52 pages - $1,000
Liver Fibrosis Global Clinical Trials Review, Q1, 2011
Apr 2011 - 57 pages - $1,000
Liver Fibrosis - Pipeline Review, Q4 2010
Dec 2010 - 29 pages - $500
Cystic Fibrosis Global Clinical Trials Review, Q2, 2011
Jun 2011 - 74 pages - $1,000
Liver Fibrosis Global Clinical Trials Review, H2, 2011
Sep 2011 - 83 pages - $1,000
Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010
Dec 2010 - 56 pages - $1,000
Cystic Fibrosis Global Clinical Trials Review, Q4, 2010
Dec 2010 - 73 pages - $1,000
Liver Fibrosis - Pipeline Review, Q2 2011
Apr 2011 - 45 pages - $500
Cystic Fibrosis - Drug Pipeline Analysis and Market Forecasts to 2015
Dec 2009 - 46 pages - $2,000
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Human therapeutics del
Therapeutic target
Hospital and Surgery del
Fibrosis del
Geographic location
South America del

Browse By

Geographic location
Argentina
Bolivia
Brazil
Chile
Colombia
Ecuador
Falkland Islands
French Guiana
Galapagos Islands
Guyana
Paraguay
Peru
South Georgia
Surinam
Uruguay
Venezuela

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us